Top Articles - Real Estate

Now.

Yes, it's a clich?, but allow me to explain why it holds true in all mar

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

kets.

In our business we love property values that grow quickly because it bu

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ilds our portfolios and makes our investors happy with their decision to purch

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ase. The flip side is that while this is happening the demand for property is

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

good and developers offer less discounts which means you need more money to in

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

est in property and therefore less people want to invest (or at least the sale

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

s are more painful for them.)

The trick is to view a constant return that you

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

will achieve.

So — when developers give you the big 15% discount, the market

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

is probably stagnant, so you'll see a net return of 15%. But when the market

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

is galloping, your capital growth will be at say 7% and your discount will be

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ower at say 8%-10%. Your net return may be around 15%-17%.

Either way you are

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

making around the same return even though you might not see it.

Of course, t

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

his is a massive oversimplification since there are so many factors that l hav

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

e overlooked but the important thing is this: you are going to need to invest

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

some money. How much will depend on the market and the structure.

If you buy

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

n a stagnant market then you get in cheap but you have to cash flow the ongoin

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

g costs so it's good for your capital and bad for your cash flow. If you buy w

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

hen it's a hot market it costs you more capital but because of the growth your

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

cash flow is better.

I hope this explains why the answer to the age old ques

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

tion of 'When should you buy?' is always Now, today, right this moment!!

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Top Articles - The Best Time To Buy Is...

Related Articles: